Research-use information. This page summarises published literature and regulator records. It is not guidance for use, not medical advice, and not a statement that any material is suitable for use in people or animals.
Glutathione is the endogenous tripeptide gamma-L-glutamyl-L-cysteinyl-glycine, the most abundant low-molecular-weight thiol in mammalian cells. Reviews describe its roles in redox homeostasis, detoxification and signalling. The catalog lists it as a research material for laboratory use only.
C10H17N3O6S70-18-8 (confirmed in PubChem)Chemistry checked against PubChem on 2026-10-05. Where the formula can be computed from the listed sequence, it was, and the two routes agree.
3 studies are cited for Glutathione. Each is labelled by design below, and each entry says what the paper measured.
PubMed returns 316 records for the search terms published on the method page (316 of them with a review publication type, 0 with a clinical-trial publication type), checked 5 October 2026.
Studies are listed by what they measured. Papers whose titles state an amount or schedule, or describe a clinical outcome of an approved medicine, are not listed. This is a wording rule, not a quality filter; see the method page.
Drugs@FDA lists 2 applications for ophthalmic irrigation solutions that contain glutathione disulfide among several ingredients. None names glutathione as a peptide medicine (checked 2026-10-05).
Drugs@FDA via openFDANo centrally authorised procedure in the EMA medicines database (checked 5 October 2026) names glutathione as an active substance. National authorisations are not in this dataset.
EMA medicines dataThe exact name returns 1092 MHRA Products documents; they mention the name in their text and were not assessed as products with it as an active substance. Checked 2026-10-05.
MHRA ProductsThe WADA 2026 Prohibited List, in force 1 January 2026 does not name this substance. The list names substances by example, so this is not a statement that it is permitted in sport.
WADA Prohibited List 2026Drugs@FDA lists two applications for ophthalmic irrigation solutions that contain glutathione disulfide among several ingredients. They are not applications for glutathione as a peptide medicine.
A regulator record is information about a database entry. It is not advice and not a statement that any use is lawful or unlawful in any country. How regulators approach research peptides.
Data dates: regulatory records 2026-10-05; WADA list 2026-10-05.
[1] Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013;1830:3143-53.
Review of glutathione biosynthesis and its regulation.
[2] Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30:1-12.
Overview of the protective roles, measurement and biosynthesis of glutathione.
[3] Meister A, Anderson ME. Glutathione. Annu Rev Biochem. 1983;52:711-60.
Annual Review of Biochemistry chapter on glutathione.
Data dates: citations read from PubMed 2026-10-05.
Peptency editorial team, last reviewed 5 October 2026. Citations are read back from PubMed, chemistry is checked against PubChem, and regulator records are read from each regulator's own database on the dates shown. The method page lists every source, search term and rule. Corrections are welcome through the contact details on the About page.
Peptency supplies laboratories and research professionals. Confirmation is remembered on this browser.
Your confirmation is remembered for 30 days.